Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 3 studies | 59% ± 16% | |
epithelial cell | 3 studies | 50% ± 23% |
Insufficient scRNA-seq data for expression of EIF3CL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 98% | 26.88 | 1423 / 1445 | 98% | 2.97 | 179 / 183 |
ovary | 100% | 38.72 | 180 / 180 | 83% | 2.11 | 358 / 430 |
stomach | 98% | 24.15 | 352 / 359 | 59% | 1.50 | 170 / 286 |
intestine | 99% | 26.19 | 955 / 966 | 30% | 0.69 | 158 / 527 |
lung | 98% | 28.37 | 564 / 578 | 24% | 0.75 | 275 / 1155 |
breast | 99% | 31.58 | 455 / 459 | 20% | 0.34 | 222 / 1118 |
brain | 92% | 20.65 | 2435 / 2642 | 27% | 0.98 | 189 / 705 |
skin | 100% | 36.10 | 1800 / 1809 | 19% | 0.32 | 91 / 472 |
thymus | 100% | 36.51 | 652 / 653 | 13% | 0.21 | 81 / 605 |
uterus | 98% | 25.78 | 167 / 170 | 10% | 0.16 | 45 / 459 |
kidney | 97% | 22.73 | 86 / 89 | 11% | 0.19 | 100 / 901 |
prostate | 100% | 28.55 | 245 / 245 | 6% | 0.08 | 28 / 502 |
bladder | 95% | 20.48 | 20 / 21 | 7% | 0.11 | 35 / 504 |
adrenal gland | 97% | 25.33 | 251 / 258 | 4% | 0.06 | 9 / 230 |
pancreas | 98% | 28.13 | 322 / 328 | 2% | 0.04 | 4 / 178 |
muscle | 100% | 44.59 | 799 / 803 | 0% | 0 | 0 / 0 |
adipose | 99% | 29.80 | 1195 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 32.51 | 1325 / 1335 | 0% | 0 | 0 / 0 |
spleen | 97% | 20.58 | 233 / 241 | 0% | 0 | 0 / 0 |
heart | 94% | 22.45 | 806 / 861 | 0% | 0 | 0 / 0 |
liver | 87% | 15.31 | 196 / 226 | 1% | 0.03 | 6 / 406 |
peripheral blood | 82% | 18.83 | 761 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 15% | 0.27 | 12 / 80 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.24 | 6 / 45 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001732 | Biological process | formation of cytoplasmic translation initiation complex |
GO_0006413 | Biological process | translational initiation |
GO_0033290 | Cellular component | eukaryotic 48S preinitiation complex |
GO_0016282 | Cellular component | eukaryotic 43S preinitiation complex |
GO_0005852 | Cellular component | eukaryotic translation initiation factor 3 complex |
GO_0003743 | Molecular function | translation initiation factor activity |
GO_0031369 | Molecular function | translation initiation factor binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | EIF3CL |
Protein name | Eukaryotic translation initiation factor 3 subunit C-like protein |
Synonyms | |
Description | FUNCTION: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. . |
Accessions | ENST00000398944.7 B5ME19 ENST00000380876.5 |